EventsThe 5th International Online Conference on Crystals
Published
This submission belongs to the session S3. Organic Crystalline Materials of the event The 5th International Online Conference on Crystals
Published date
10 Jun, 2026
Academic Editor
author-avatarStanislav Ferdov
Citation
Muminjon Hakimov, Isroiljon Ortikov, Ibragimdjan Abdugafurov, Burkhon Elmuradov, Akmaljon Tojiboev, Synthesis and crystal structure of 3-((1-(p-tolyl)-1H-1,2,3-triazol-4-yl)methyl)thieno[3,2-d]pyrimidin-4(3H)-one, in Proceedings of The 5th International Online Conference on Crystals, 15 June–17 June 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Synthesis and crystal structure of 3-((1-(p-tolyl)-1H-1,2,3-triazol-4-yl)methyl)thieno[3,2-d]pyrimidin-4(3H)-one

Isroiljon Ortikov 1
Muminjon Hakimov 2
Ibragimdjan Abdugafurov 3
Burkhon Elmuradov 4
Akmaljon Tojiboev 5
1. Department of Methodology for Teaching Chemistry, Andijan State Pedagogical Institute, Andijan 170011, Uzbekistan, Uzbekistan
2. Department of Chemistry, Namangan State University, Namangan 160107, Uzbekistan, Uzbekistan
3. Organic and Petrochemical, National University of Uzbekistan named after Mirzo Ulugbek, Tashkent 100174, Uzbekistan, Uzbekistan
4. Department of Organic Synthesis, The Institute of the Chemistry of Plant Substances named acad. S.Yu.Yunusov of the Academy of Sciences of the Republic of Uzbekistan, Tashkent, Uzbekistan, Uzbekistan
5. Department of AI and Natural Sciences, University of Geological Sciences, Tashkent 100170, Uzbekistan, Uzbekistan
Abstract

The five-membered heterocyclic compounds with a heteroatom of the sequence N-N-N are copper(1)-catalysed azide–alkyne cycloaddition reactions. In the case of anticancer drugs, there are several specific requirements: they must be stable and non-differentiating between cancer and non-cancerous cells, have minimal toxicity and lack side effects, requiring different mechanisms for successful treatment. In recent years, 1,2,3-triazoles have become one of the most attractive research objects in heterocyclic chemistry [1]. 1H-1,2,3-Triazoles are used in pharmaceuticals as anti-inflammatory agents and as herbicides in agriculture. In addition, 1,2,3-triazoles have antimicrobial, anti-inflammatory, anti-leishmania, and antidiabetic activities [2]. In the present study, we provide a detailed structural analysis of 3-((1-(p-tolyl)-1H-1,2,3-triazol-4-yl)methyl)thieno[3,2-d]pyrimidin-4(3H)-one (1) based on experimental X-ray diffraction. We conducted a 1,3-bipolar cycloaddition reaction of synthesised propargyl ethers using para-azidobenzoic acid ethyl ether. The progress of the reaction was monitored by thin-layer chromatography. The precipitate was filtered off, dried and recrystallised through methanol; the product was obtained at an 84% yield. Compounds 1 crystallise in the orthorhombic space group Pna21. The asymmetric unit of a title compound consists of one molecule. Energy framework analysis is an important quantitative analysis of the interaction energies and architecture of molecules in a single crystal. It can give information on the interaction energy of new triazole organic compounds, for example, and can detect interactions such as C–H··· π, C–O··· π, C–N··· π; in addition, Hirshfeld surface analysis provides information about the interaction between close contacts of hydrogen and another molecule in the triazole compounds. In one crystal, the central 1,2,3-triazole and benzene rings are almost planar. In the crystal structure of the title compound, the molecules are linked by intermolecular C—H⋯O, C—H⋯S, and C—H⋯N hydrogen bonds. These interactions, in combination with C—H⋯Cg, contact form a three-dimensional framework.

Keywords
synthesis
crystal structure
1,2,3-triazole
Hirshfeld surface analysis
hydrogen bonds.
Quantitative Raman Spectroscopic Analysis of Crystallographic and Molecular Orientation in Rubrene Films
Comparative study of fluid inclusions in Dicumyl and Benzoyl Peroxides